Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059800 · ClinicalTrials.gov registry record · Phase 2
Boron Neutron Capture Therapy in Treating Patients With Melanoma
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00059800 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center.
The verdict
NCT00059800, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue. PURPOSE: Phase II trial to study the effectiveness of boron neutron capture therapy in treating patients who have melanoma.
Interventions
- RADIATION boron neutron capture therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-05 |
| Est. Completion | 2004-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059800
The ClinicalTrials.gov registry entry for NCT00059800 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which boron neutron capture therapy is the first listed.
NCT00059800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00059800 about?
NCT00059800 is a clinical study titled "Boron Neutron Capture Therapy in Treating Patients With Melanoma". RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue. PURPOSE: Phase II trial to study the effectiveness of boron neutron capture therapy in treating patients who have melanoma.
What is the current status of trial NCT00059800?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-05. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00059800?
The interventions under investigation include: boron neutron capture therapy (RADIATION).
Who is sponsoring clinical trial NCT00059800?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.